Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-23T02:12:54.431Z Has data issue: false hasContentIssue false

Policy Implications of the Society for Healthcare Epidemiology of America's Research Plan for Reducing Healthcare-Associated Infections

Published online by Cambridge University Press:  02 January 2015

Kurt B. Stevenson*
Affiliation:
Division of Infectious Diseases, The Ohio State University College of Medicine, Columbus
Steven Gordon
Affiliation:
Department of Infectious Diseases, The Cleveland Clinic, Cleveland, Ohio
*
Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University College of Medicine, N-1122 Doan Hall, 410 West 10th Avenue, Columbus, OH 43210, ([email protected])

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kohn, LT, Corrigan, J, Donaldson, MS; Institute of Medicine. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press, 2000.Google Scholar
2.Institute of Medicine; Committee on Quality of Health Care in American. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press, 2001.Google Scholar
3.Gerberding, JL. Hospital-onset infections: a patient safety issue. Ann Intern Med 2002;137:665670.CrossRefGoogle ScholarPubMed
4.Burke, JP. Infection control—a problem for patient safety. N Engl J Med 2003;348:651656.CrossRefGoogle ScholarPubMed
5.Pronovost, PJ, Miller, MR, Wachter, RM. Tracking progress in patient safety: an elusive target. JAMA 2006;296:696699.Google Scholar
6.McKibben, L, Horan, TC, Tokars, JI, et al.Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 2005;26:580587.Google Scholar
7.McKibben, L, Fowler, G, Horan, T, Brennan, PJ. Ensuring rational public reporting systems for health care-associated infections: systematic literature review and evaluation recommendations. Am J Infect Control 2006;34:142149.Google Scholar
8.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L. Management of mul-tidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35:S165S193.CrossRefGoogle Scholar
9.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35:S65S164.CrossRefGoogle ScholarPubMed
10.Muto, CA, Jernigan, JA, Ostrowsky, BE, et, al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24:362386.CrossRefGoogle ScholarPubMed
11.Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S1S92. http://www.journals.uchicago.edu/toc/iche/2008/29/s1. Accessed September 23, 2009.Google Scholar
12.Institute of Medicine (IOM). Respiratory protection for healthcare workers in the workplace against novel H1N1 influenza A: a letter report. Washington, DC: National Academies Press; September 1, 2009. http://www.nap.edu/catalog.phpirecord_id = 12748. Accessed December 28, 2009.Google Scholar
13.Research Committee of the Society of Healthcare Epidemiology of America. Enhancing patient safety by reducing healthcare-associated infections: the role of discovery and dissemination. Infect Control Hosp Epidemiol 2010;31:118123 (in this issue).CrossRefGoogle Scholar
14.Westfall, JM, Mold, J, Fagnan, L. Practice-based research—“blue highways” on the NIH roadmap. JAMA 2007;297:403406.CrossRefGoogle ScholarPubMed
15.Dougherty, D, Conway, PH. The “3T's” road map to transform US health care: the “how” of high-quality care. JAMA 2008;299:23192321.CrossRefGoogle Scholar
16.Khoury, MJ, Gwinn, M, Yoon, PW, Dowling, N, Moore, CA, Bradley, L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665674.Google Scholar
17.Iglehart, JK. Prioritizing comparative-effectiveness research—IOM recommendations. N Engl J Med 2009;361:325328.CrossRefGoogle ScholarPubMed
18.Brook, RH. Possible outcomes of comparative effectiveness research. JAMA 2009;302:194195.Google Scholar
19.HHS.gov/Recovery. Comparative effectiveness research funding, http://www.hhs.gov/recovery/programs/cer/. Accessed September 23, 2009.Google Scholar
20.Department of Health and Human Services. American Recovery and Reinvestment Act. Supporting comparative effectiveness research. Agency for Healthcare Research and Quality: comparative effectiveness research, http: //www.hhs.gov/recovery/reports/plans/ahrq_cer_plan.pdf. Accessed September 23, 2009.Google Scholar
21.Centers for Disease Control and Prevention (CDC). Prevention Epicenter Program, http://www.cdc.gov/ncidod/dhqp/epicenter.html. Accessed September 23, 2009.Google Scholar